New pill PG-033 tested for safety in first human trial
Symptom relief
Not yet recruiting
This Phase 1 trial will test the safety and tolerability of multiple doses of PG-033 tablets in 30 healthy adults. Participants will be randomly assigned to receive either PG-033 or a placebo. The study aims to find out how the drug moves through the body and whether it causes an…
Phase: PHASE1 • Sponsor: Prime Gene Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC